To include your compound in the COVID-19 Resource Center, submit it here.

Follow-on roundup: Karuna, CRISPR, Molecular Therapeutics, OptiNose

Since market close on Wednesday, Karuna, CRISPR Therapeutics, Molecular Therapeutics and OptiNose have raised an aggregate of more than $600 million in follow-ons.

Karuna Therapeutics Inc. (NASDAQ:KRTX) raised $250 million late Wednesday through the sale of 2.6 million shares at $96, the same price as

Read the full 447 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers